MedTrace Logo

Pancreatic Stone Protein (PSP) in Pregnant Women

NCT02247297 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 486

Last updated 2018-11-26

No results posted yet for this study

Summary

This prospective, single centred cohort study evaluates the physiological course of the potentially novel biomarker PSP in pregnant women as well as its predictive role in the development of inflammatory complications during pregnancy.

Conditions

  • Pregnancy
  • HELLP Syndrome
  • Preterm Premature Rupture of Fetal Membranes
  • Preeclampsia

Interventions

PROCEDURE

Blood collection

Diagnostic blood collection

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Nicole Ochsenbein

    lead OTHER

Principal Investigators

  • Nicole Ochsenbein, Prof. Dr. · University of Zurich

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247297 on ClinicalTrials.gov